PSM Publications
Intelligence Alert: Unlicensed med spas are selling unregulated diabetes and weight loss injectables that threaten public safety
Based on recent investigative reporting by the Partnership for Safe Medicines (PSM), patients in your state may be receiving weight loss injectables from unlicensed sources that do not meet FDA requirements for safety and sterility. PSM has established a dedicated contact from CBP/HSI to support investigations by state law enforcement on this issue.
[...]Threats to HIV patients from criminals in the drug supply chain
Since 2019, federal prosecutors, drug manufacturers, and patient safety organizations have uncovered extensive criminal schemes targeting HIV medicines at every point in the supply chain. These schemes undermine trust in the healthcare system, and they endanger patients.
[...]Prescription Drug Freight Fraud Report, October 2025
What large-scale commercial imports made it into the country between March and August of 2025?
[...]Med spas need stronger regulation
Medical spas and wellness clinics are operating on the edge of existing regulatory frameworks and it’s a risk to American patients.
[...]Prescription Drug Freight Fraud Report, September 2025
Our analysis of data from June and July revealed hundreds of pharmaceutical shipments that entered the U.S. from facilities no one would expect, including unregistered Chinese exporters and alternative medicine clinics abroad.
[...]Handout: The fake pill trade hasn’t gone away
Handout: The fake pill trade hasn’t gone away It’s been 10 years since deadly counterfeit prescription pills began killing Americans. News about fake pill deaths has become commonplace and advocates have made progress to protect lives, but many people still don’t know about this threat or the pill presses that make it possible. Share this…
[...]Prescription Drug Freight Fraud Report, July 2025
What if your tirzepatide shipment came from a Brazilian beauty clinic? Or a vial of semaglutide was manufactured, supposedly, at a Costco in Toronto? In April and May 2025, dozens of shipments of semaglutide, tirzepatide, apixaban, and antibiotics entered the U.S. from facilities that aren’t in the FDA’s drug manufacturing database. These aren’t low-volume personal-use…
[...]Pill press update: January through June 2025
Pill presses and molds are used to make fake pills with deadly consequences thousands of people every year. The number of Americans that take fake pills annually without a fatal event is even higher. Read our January through June 2025 report covering pill press seizures, policy developments, and legislation.
[...]Prescription Drug Freight Fraud Report, May 2025
What if your blood thinners were made in an unverified location in Colombia? In March 2025, dozens of pharmaceutical shipments entered the U.S. that were manufactured in places no one would expect.
[...]Handout: Illegal ingredients linked to knockoff weight loss drugs pouring in from foreign sources
Compounded versions of GLP-1 injectable treatments for diabetes and obesity have surged in popularity despite a lack the safety and efficacy assurances. The FDA has warned that these knockoff versions sometimes contain illicit semaglutide or tirzepatide—the active pharmaceutical ingredients (APIs) in weight loss drugs. Working with George Karavetsos, former director of FDA’s Office of Criminal…
[...]